Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
SILO
#3953
Silo Pharma, Inc. Common Stock
0.3
7
+5.71%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+5.71%
Variazione Mensile
-2.63%
Variazione di 6 mesi
-42.19%
Variazione Annuale
-72.59%
Chiusura Precedente
0.3
5
Open
0.3
7
Bid
Ask
Low
0.3
7
High
0.3
7
Volume
3
Mercati
Mercato Azionario Statunitense
Salute
SILO
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.7 M
1.97 M
3.16 M
2.84 M
4.48 M
—
Valuation ratios
Enterprise value
—
—
-1.67 M
799.02 K
85.37 K
9.06 M
Price to earnings ratio
—
—
-1.8
-1.27
-0.75
-3.14
Price to sales ratio
—
—
81.8
64.93
45.43
185.68
Price to cash flow ratio
—
—
-2
-1.45
-0.85
-2.99
Price to book ratio
—
—
0.68
0.76
0.65
1.14
Enterprise value to EBITDA ratio
—
—
—
—
-0.02
—
Profitability ratios
Return on assets %
2.13
0.37
-0.34
-0.48
-0.59
-0.76
Return on equity %
2.37
0.43
-0.38
-0.6
-0.87
-1.07
Return on invested capital %
4 129.66
-5 369.36
-4 045.39
-4 981.19
-7 388.04
-5 936.51
Gross margin %
-330.38
1
77.29
91.9
91.9
260.94
Operating margin %
6 287.34
-41.21
-4 231.34
-5 347.41
-6 526.44
-29.44 K
EBITDA margin %
-4 912.8
—
—
—
-6 517.86
-29.38 K
Net margin %
7 422.52
58.62
-4 558.98
-5 132.57
-6 092.59
-28.16 K
Liquidity ratios
Quick ratio
9.83
21.17
—
—
—
—
Current ratio
10.07
21.23
26.52
9.9
4.29
23.8
Inventory turnover
1.86
0
—
—
—
—
Asset turnover
0.04
1.12
0.01
0.01
0.01
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
0.04
0.01
—
—
Long term debt to total equity ratio
0
0
0.04
0.01
—
—
Per share metrics
Operating cash flow per share
—
-1.19
-1.53
-1.05
-1.04
-0.92
EBIT per share
—
2
-1.58
-1.25
-1.28
-1.06
EBITDA per share
—
—
—
—
-1.28
-1.06
Total debt per share
—
—
—
—
—
—
Cash per share
—
5.13
4.98
2.49
1.92
4.76
Net current asset value per share
—
5.42
5.07
2.49
1.93
4.86
Tangible book value per share
—
4.72
4.53
2.01
1.3
3.4
Working capital per share
—
5.17
4.88
2.24
1.48
3.9
Book value per share
—
4.72
4.53
2.01
1.37
3.58
Notizie
Le azioni di Silo Pharma salgono con il programma di riacquisto da 1 mln $
Silo Pharma stock surges on $1M share buyback program
Silo Pharma autorizza un programma di riacquisto azioni da 1 milione di dollari
Silo Pharma authorizes $1 million stock buyback program
Il Giappone concede un brevetto per il trattamento PTSD di Silo Pharma
Japan grants patent for Silo Pharma’s PTSD treatment
Silo Pharma firma lettera d’intenti con Allucent per studi clinici su spray nasale SPC-15
Silo Pharma signs LOI with Allucent for SPC-15 nasal spray clinical trials
Il CEO di Silo Pharma Weisblum acquista azioni della società per $735
Silo Pharma CEO Weisblum buys $735 in company stock
Silo Pharma selects Allucent to support PTSD treatment IND submission
Silo Pharma sceglie il fondo Alphaledger T12 per investimenti in asset blockchain